Nexgen Plasma Atomization System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: Cloud DX, New Oroperu Resources, Todos Medical, Kainantu Resources, CleanSpark UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Cloud DX Inc (CVE:CDX) said Brad Miller, a director of the company (formerly Roosevelt Capital Group), as a result of the previously announced qualifying transaction and related transactions, had acquired beneficial ownership and control over 7,307,337 shares and 100,000 share purchase warrants issued to B and M Miller Equi...

NA Proactive news snapshot: The Good Shroom Co, Golden Minerals, Codebase Ventures, Vicinity Motor … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive The Good Shroom Co Inc. (CVE:MUSH), previously Cluny Capital Corp, (CVE:CLN.H), a Toronto Venture Exchange (TSX) capital pool company, has announced the completion of its qualifying transaction, which involved the amalgamation of Teonan Biomedical Inc. with the company's wholly-owned subsidiary, as part of a three-cornered amalgamation...

PyroGenesis says its Additive Manufacturing NexGen Powder production line now in place and producing powders NexGen Plasma Atomization System, with its production rate exceeding 25 kg/h, has shattered all published plasma-atomized production rates for titanium known to management Several major top-tier aerospace companies and OEMs, are awaiting powders from PyroGenesis’ new, state-of-the-art NexGen production line PyroGenesis Canada Inc (TSE:PYR) (NASDAQ:PYR) (FRA:8PY) has announced that its cutting-edge Additive Manufacturing (AM) NexGen Powder production line is now in place a...

NA Proactive news snapshot: Todos Medical, Kainantu Resources, CleanSpark, Arcadia Biosciences UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Todos Medical Ltd (OTCQB:TOMDF) has announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 clinical trial of antiviral Tollovir for the treatment of hospitalized coronavirus (COVID-19) patients. The trial is being conducted at Shaare Zedek Medical Center in Jerusalem, Israel, and will evaluate the safety a...